Sagimet Biosciences (SGMT) Cash from Financing Activities (2023 - 2024)
Historic Cash from Financing Activities for Sagimet Biosciences (SGMT) over the last 2 years, with Q2 2024 value amounting to -$27000.0.
- Sagimet Biosciences' Cash from Financing Activities rose 9703.3% to -$27000.0 in Q2 2024 from the same period last year, while for Sep 2024 it was $104.8 million, marking a year-over-year change of. This contributed to the annual value of $104.8 million for FY2024, which is 2164.63% up from last year.
- According to the latest figures from Q2 2024, Sagimet Biosciences' Cash from Financing Activities is -$27000.0, which was up 9703.3% from $104.8 million recorded in Q1 2024.
- Over the past 5 years, Sagimet Biosciences' Cash from Financing Activities peaked at $104.8 million during Q1 2024, and registered a low of -$910000.0 during Q2 2023.